Rossari Biotech Limited
NSE:ROSSARI.NS
817.8 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 1,306.89 | 1,442.19 | 1,362.75 | 1,064.27 | 880.59 | 633.92 | 374.74 | 142.85 |
| Depreciation & Amortization
| 603.9 | 629.31 | 480.55 | 228.29 | 168.52 | 122.64 | 51.73 | 43.45 |
| Deferred Income Tax
| 0 | -482.95 | -524.01 | -335.38 | -214.91 | 0 | 0 | 0 |
| Stock Based Compensation
| 6.87 | 9.43 | 18.31 | 16.27 | 4.63 | 0 | 0 | 0 |
| Change In Working Capital
| -1,568.48 | -271.97 | -1,129.91 | -483.05 | -310.68 | 113.91 | -99.14 | -148.29 |
| Accounts Receivables
| -1,126.34 | -279.69 | -425.28 | -404.5 | -204.06 | -344.23 | -110.86 | -226.43 |
| Inventory
| -938.48 | 7.32 | -481.85 | -320.25 | -37.65 | -214.02 | -101.2 | 5.8 |
| Accounts Payables
| 496.34 | 0.4 | -222.78 | 241.7 | -68.97 | 672.19 | 110.85 | 72.34 |
| Other Working Capital
| 496.34 | 0 | 0 | 0 | 0 | -0.03 | 2.06 | 0 |
| Other Non Cash Items
| 2,733.67 | 197.93 | 85.89 | -12.73 | 20.13 | -158.7 | -71.64 | 244.13 |
| Operating Cash Flow
| 299.7 | 1,523.94 | 293.58 | 477.67 | 548.28 | 711.77 | 255.69 | 46.95 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -1,312.83 | -328.76 | -382.25 | -580.84 | -759.71 | -439.91 | -139.25 | -39.12 |
| Acquisitions Net
| -122.39 | -985.31 | -3,550.01 | -43.39 | -43.93 | 0.01 | 0 | 0 |
| Purchases Of Investments
| -90.23 | -534.37 | 68.8 | -195.31 | -181.31 | -69.4 | -69.11 | 0 |
| Sales Maturities Of Investments
| 466.27 | 534.37 | 15.54 | 195.31 | 181.31 | 69.39 | 0 | 0 |
| Other Investing Activites
| 458.02 | -494.87 | 859.13 | 252.44 | -1,099.37 | 75.69 | -65.12 | -1.27 |
| Investing Cash Flow
| -1,059.18 | -1,808.94 | -2,988.79 | -371.79 | -1,903.01 | -364.22 | -204.37 | -40.39 |
| Financing Activities: | ||||||||
| Debt Repayment
| -318.99 | -655.01 | -48.12 | -339.6 | -24.16 | -521.54 | -48.71 | -34.74 |
| Common Stock Issued
| 38.45 | 42.12 | 3,015.05 | 426.53 | 1,000 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -655.01 | -2,966.93 | -309.47 | -975.84 | 0 | 0 | 0 |
| Dividends Paid
| -27.58 | -27.53 | -27.53 | -25.38 | -26.48 | -105.92 | -2.65 | 0 |
| Other Financing Activities
| 313.36 | 1,903.98 | 2,945.43 | 2 | 1,595.91 | 335.96 | -13.59 | 27.18 |
| Financing Cash Flow
| 321.74 | 608.55 | 2,917.9 | -245.92 | 1,569.43 | -291.5 | -64.95 | -7.56 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -2.54 | 2.02 | 0 | 0.01 | 19.99 | -4.88 | -1.47 | 2.25 |
| Net Change In Cash
| -396.21 | 323.55 | 222.69 | -140.03 | 234.69 | 51.17 | -15.1 | 1.25 |
| Cash At End Of Period
| 302.11 | 698.32 | 374.77 | 152.08 | 292.11 | 57.42 | 6.25 | 21.35 |